Confluent Biotech Capital Partners, LP
Confluent Biotech Capital Partners, LP is a hedge fund based in Teaneck, New Jersey. According to its most recent Form D, filed Sep 25, 2019, the fund has sold $1,300,000 of interests to 5 investors since its first sale in Jan 2014. The minimum investment it accepts from an outside investor is $250,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Daniel Brothman; Steven Furer.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $1,300,000Cumulative sales reported on Form D
- Investors
- 5
- First sale
- Jan 1, 2014
- Minimum investment
- $250,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Daniel Brothman; Steven Furer
- Latest Form D
- Sep 25, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Sep 25, 2019 | Form D/A (amendment) | $1,300,000 | 5 | SEC.gov ↗ |
| Sep 19, 2018 | Form D/A (amendment) | $1,300,000 | 5 | SEC.gov ↗ |
| Sep 19, 2017 | Form D/A (amendment) | $1,250,000 | 4 | SEC.gov ↗ |
| Sep 19, 2016 | Form D/A (amendment) | $1,250,000 | 4 | SEC.gov ↗ |
| Sep 17, 2015 | Form D | $0 | 0 | SEC.gov ↗ |
5 Form D filings in the SEC's electronic records (2008 onward), the earliest on Sep 17, 2015. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Confluent Biotech Capital Partners, LP
What is the minimum investment for Confluent Biotech Capital Partners, LP?
According to its latest Form D, filed Sep 25, 2019, the minimum investment Confluent Biotech Capital Partners, LP accepts from an outside investor is $250,000.
Who can invest in Confluent Biotech Capital Partners, LP?
Confluent Biotech Capital Partners, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Confluent Biotech Capital Partners, LP raised?
Confluent Biotech Capital Partners, LP reports $1,300,000 sold from 5 investors on its Form D filed Sep 25, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is Confluent Biotech Capital Partners, LP based?
Confluent Biotech Capital Partners, LP is based in Teaneck, New Jersey.
When did Confluent Biotech Capital Partners, LP launch?
Confluent Biotech Capital Partners, LP reports its first sale in Jan 2014.
Size compared with every hedge fund
Raised more than 23% of the 213 hedge funds based in New Jersey, and more than 7% of all 10,153 that report sales.